Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

Summary

The primary objective of this study is to evaluate the effect of 12 weeks of treatment with once daily administration of AQX-1125 compared to placebo on change from baseline in Total Lesion Symptom Score in subjects with mild to moderate atopic dermatitis

Timeline

Start

2014-12

Primary completion

2015-11

Completion

2015-12

Drugs

Indications